Indo US Bio-Tech Limited has announced its standalone audited financial results for the quarter and year ended March 31, 2026. For the quarter ended March 31, 2026, the company reported revenue from operations of 2,602.17 Lakhs and a net profit of 197.17 Lakhs. Compared to the previous quarter (Q3 FY 2026), revenue increased by 14.14% from 2,279.83 Lakhs, while net profit decreased by 34.20% from 299.66 Lakhs. Compared to the corresponding quarter of the last year (Q4 FY 2025), revenue increased by 87.94% from 1,384.60 Lakhs, while net profit decreased by 46.49% from 368.48 Lakhs.

Indo US Bio-Tech Limited is an ISO-certified company primarily engaged in the business of seed cultivation, processing, and trading. The company focuses on the production and processing of commercial and vegetable seeds across India, utilizing various leased lands and seed production agreements with farmers.

The company’s audited financial results for the period ended March 31, 2026, were approved by the Board of Directors on May 29, 2026, and received an unmodified opinion from the statutory auditors. Regarding financial performance for the full fiscal year 2026, the company reported a net profit of 1,312.29 Lakhs compared to 1,626.74 Lakhs in the previous year. As per the notes to the financial results, the company reported no pending investor complaints during the period under review. Information regarding famous investors is not available in the provided notice.